Richard Schallhorn
Corporate Officer/Principal chez Insightec Ltd.
Profil
Richard Schallhorn is currently the Vice President-Neurosurgery at Insightec Ltd.
He previously worked as a Principal at Medtronic, Inc. and as Vice President-Marketing & Operations at CoAxia, Inc. Schallhorn received his undergraduate degree from Marquette University and his graduate degree from the University of Miami.
Postes actifs de Richard Schallhorn
| Sociétés | Poste | Début |
|---|---|---|
Insightec Ltd.
 Insightec Ltd. Medical SpecialtiesHealth Technology InSightec Ltd. engages in the development of incisionless surgery through magnetic resonance-guided focused ultrasound technology. Its products include exablate neuro, exablate body system, and exablate prostate. It focuses on the treatment of tremors, Parkinson?s disease, uterine fibroids, bone metastases, and focal prostate cancer. The company was founded by Jackob Vortman and Tamir Oded on March 9, 1999 and is headquartered in Tirat Carmel, Israel. | Corporate Officer/Principal | 01/01/2013 |
Anciens postes connus de Richard Schallhorn
| Sociétés | Poste | Fin |
|---|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
CoAxia, Inc.
 CoAxia, Inc. Medical/Nursing ServicesHealth Services CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders. CoAxia was founded in 1999 by Denise Barbut MD. | Directeur des opérations | - |
Formation de Richard Schallhorn
| Marquette University | Undergraduate Degree |
| University of Miami | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
CoAxia, Inc.
CoAxia, Inc. Medical/Nursing ServicesHealth Services CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders. CoAxia was founded in 1999 by Denise Barbut MD. | Health Services |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
Insightec Ltd.
Insightec Ltd. Medical SpecialtiesHealth Technology InSightec Ltd. engages in the development of incisionless surgery through magnetic resonance-guided focused ultrasound technology. Its products include exablate neuro, exablate body system, and exablate prostate. It focuses on the treatment of tremors, Parkinson?s disease, uterine fibroids, bone metastases, and focal prostate cancer. The company was founded by Jackob Vortman and Tamir Oded on March 9, 1999 and is headquartered in Tirat Carmel, Israel. | Health Technology |